-
DE
Lobar pneumonia is a bacterial lung infection affecting an entire lobe of the lung. It typically presents with sudden onset and requires prompt medical treatment.
Lobar pneumonia is a bacterial lung infection affecting an entire lobe of the lung. It typically presents with sudden onset and requires prompt medical treatment.
Lobar pneumonia is a type of lung infection (pneumonia) in which an entire lobe of the lung (lobus pulmonis) becomes inflamed and filled with fluid or pus. Unlike bronchopneumonia, which affects multiple patchy areas throughout the lungs, lobar pneumonia involves a uniform consolidation of a single lobe. It is one of the classic forms of bacterial pneumonia and most commonly affects otherwise healthy adults.
The most common causative organism is Streptococcus pneumoniae (pneumococcus). Other potential pathogens include:
Risk factors that predispose individuals to lobar pneumonia include a weakened immune system, smoking, chronic lung disease, advanced age, alcohol misuse, and preceding viral respiratory infections such as influenza.
Lobar pneumonia typically has a sudden and severe onset. Common symptoms include:
Classic lobar pneumonia is described as progressing through four histological stages: congestion, red hepatization, grey hepatization, and resolution (lysis).
Diagnosis is established through a combination of clinical assessment and diagnostic tests:
Since lobar pneumonia is primarily bacterial in origin, antibiotic therapy is the cornerstone of treatment. The first-line agents for pneumococcal pneumonia are amoxicillin or penicillin G. When atypical organisms are suspected or the pathogen is unknown, macrolide antibiotics (e.g., clarithromycin) or fluoroquinolones may be used. Treatment duration is typically 5 to 10 days.
In addition to antibiotic therapy, the following supportive measures are important:
Mild cases may be managed on an outpatient basis. However, hospitalization is required for patients with severe symptoms, significant comorbidities, advanced age, or complications such as pleural effusion or sepsis. Disease severity is commonly assessed using standardized tools such as the CRB-65 score.
With timely and appropriate treatment, most patients recover fully from lobar pneumonia. Possible complications include:
Elderly individuals, those with chronic underlying conditions, and immunocompromised patients are at highest risk for severe disease and complications.
The most effective preventive measure against pneumococcal lobar pneumonia is pneumococcal vaccination. It is recommended for infants, adults aged 60 and over, and individuals with chronic illnesses or immune deficiency. Influenza vaccination also provides indirect protection, as flu infections are a known risk factor for developing secondary bacterial pneumonia.
For Healthy Oral Flora & Dental Care
Formulated lozenges with Dentalac®, lactic acid bacteria, and Lactoferrin CLN®
For Healthy Oral Flora & Dental Care
Formulated lozenges with Dentalac®, lactic acid bacteria, and Lactoferrin CLN®
For your universal protection
As one of the most valuable proteins in the body, lactoferrin is a natural component of the immune system.
For your iron balance
Specially formulated for your iron balance with plant-based curry leaf iron, Lactoferrin CLN®, and natural Vitamin C from rose hips.